Literature DB >> 6787909

Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction.

H G McDaniel, S E Papapietro, W J Rogers, J A Mantle, L R Smith, R O Russell, C E Rackley.   

Abstract

Total and individual plasma free fatty acids (FFA) were measured on admission and over the next 4 days in 24 patients admitted to the hospital with chest pain and suspected acute myocardial infarction (AMI). In a prospective randomized fashion, the patients were either given an infusion of 300 gm of glucose, 50 units of insulin, and 80 mEq of KCl per liter at a rate of 1.5 ml/kg/hr over the initial 48 hours of hospitalization, or they served as controls receiving conventional therapy. Eleven patients were in the control group and 13 were in the glucose-insulin-potassium (G-I-K) group. Twenty-one of the patients had an AMI by CK-MB rise and ECG changes (in the G-I-K group three did not evolve AMI). The total plasma FFA were 840 +/- 134 microM/L in the controls and 933 +/- 160 microM/L in the G-I-K group initially (prestudy). Total FFA rapidly fell in the G-I-K group and then rebounded when G-I-K was stopped. In contrast, total FFA values fell gradually in the control group over the 4-day period. The individual FFA had similar percentages initially in the two groups. In the control group the percent of individual plasma FFA was unchanged over the period studied, although there was some mild random day-to-day fluctuation. In contrast in the G-I-K group linoleic acid fell both during and after the infusion was stopped (26.8% to 19.1% P less than 0.001). Arachidonic acid doubled in percentage of the total FFA value during G-I-K infusion (3.1% to 6.5%, P less than 0.002) and returned to the control value when it was stopped. Thus G-I-K infusion during AMI reduces the total level of plasma FFA while increasing the percent of arachidonic and decreasing the percent of linoleic acid, observations proposed to reflect improved membrane stability of the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787909     DOI: 10.1016/0002-8703(81)90406-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  The effect of insulin on the heart : Part 1: Effects on metabolism and function.

Authors:  L J Klein; F C Visser
Journal:  Neth Heart J       Date:  2010-04       Impact factor: 2.380

2.  Serum lipids during treatment with glucose-insulin-potassium in myocardial infarction.

Authors:  O J Kirkeby; C Risöe; K Kirkeby; I Hjermann
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

Review 3.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

4.  Hyperinsulinemic Normoglycemia Does Not Meaningfully Improve Myocardial Performance during Cardiac Surgery: A Randomized Trial.

Authors:  Andra E Duncan; Babak Kateby Kashy; Sheryar Sarwar; Akhil Singh; Olga Stenina-Adognravi; Steffen Christoffersen; Andrej Alfirevic; Shiva Sale; Dongsheng Yang; James D Thomas; Marc Gillinov; Daniel I Sessler
Journal:  Anesthesiology       Date:  2015-08       Impact factor: 7.892

5.  High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study.

Authors:  Yanhui Li; Lin Zhang; Lei Zhang; Haiyong Zhang; Nianzhong Zhang; Zhongsu Yang; Mingming Gao; Xinchun Yang; Liang Cui
Journal:  J Cardiovasc Dis Res       Date:  2010-07

6.  Polyunsaturated fatty acids of serum lipids in myocardial infarction.

Authors:  J W Crofts; P L Ogburn; S B Johnson; R T Holman
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

7.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.